Literature DB >> 9051918

Virulent and avirulent Entamoeba histolytica and E. dispar differ in their cell surface phosphorylated glycolipids.

S Moody1, S Becker, Y Nuchamowitz, D Mirelman.   

Abstract

Virulent strains of Entamoeba histolytica have been reported to produce a mixture of phosphoglycoconjugates that share some structural features with the lipophosphoglycans (LPGs) of Leishmania. Purification of these glycoconjugates is essential to their precise structural characterization. In this study we have extracted 'LPG-like' molecules from various virulent E. histolytica strains and purified on the basis of charge differences, 2 apparently related glycoconjugates a 'LPG' and a 'lipophosphopeptidoglycan (LPPG)'. In marked contrast to the abundance of these 'LPG' and 'LPPG' molecules in the virulent strains, avirulent E. histolytica and E. dispar strains produce either very low, or no detectable levels of LPG, and either low levels or modified forms of 'LPPG'. Monospecific polyclonal antibodies prepared against that 'LPG' of the virulent strain HM-1:1MSS c16 identified epitopes shared between both the 'LPG' and the 'LPPG' of this and other virulent strains, using Western blot analysis. Flow cytometric analysis of a range of strains using these antibodies identified a surface distribution of these molecules and confirmed a correlation between surface exposure of epitopes bound by these antibodies and parasite virulence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9051918     DOI: 10.1017/s0031182096008396

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  17 in total

1.  Comparison of use of enzyme-linked immunosorbent assay-based kits and PCR amplification of rRNA genes for simultaneous detection of Entamoeba histolytica and E. dispar.

Authors:  D Mirelman; Y Nuchamowitz; T Stolarsky
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Protection against invasive amebiasis by a single monoclonal antibody directed against a lipophosphoglycan antigen localized on the surface of Entamoeba histolytica.

Authors:  A Marinets; T Zhang; N Guillén; P Gounon; B Bohle; U Vollmann; O Scheiner; G Wiedermann; S L Stanley; M Duchêne
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

3.  Reduction of cell surface glycosylphosphatidylinositol conjugates in Entamoeba histolytica by antisense blocking of E. histolytica GlcNAc-phosphatidylinositol deacetylase expression: effect on cell proliferation, endocytosis, and adhesion to target cells.

Authors:  Divya Vats; Ram A Vishwakarma; Sudha Bhattacharya; Alok Bhattacharya
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Entamoeba histolytica induces intestinal cathelicidins but is resistant to cathelicidin-mediated killing.

Authors:  Eduardo R Cobo; Chen He; Ken Hirata; Grace Hwang; UyenPhuong Tran; Lars Eckmann; Richard L Gallo; Sharon L Reed
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

5.  Entamoeba histolytica: Host parasite interactions at the colonic epithelium.

Authors:  Steve Cornick; Kris Chadee
Journal:  Tissue Barriers       Date:  2017-01-02

6.  A monoclonal antibody to the amebic lipophosphoglycan-proteophosphoglycan antigens can prevent disease in human intestinal xenografts infected with Entamoeba histolytica.

Authors:  Zhi Zhang; Michael Duchêne; Samuel L Stanley
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

Review 7.  The role of lipopeptidophosphoglycan in the immune response to Entamoeba histolytica.

Authors:  Isabel Wong-Baeza; Marcela Alcántara-Hernández; Ismael Mancilla-Herrera; Itzmel Ramírez-Saldívar; Lourdes Arriaga-Pizano; Eduardo Ferat-Osorio; Constantino López-Macías; Armando Isibasi
Journal:  J Biomed Biotechnol       Date:  2010-01-21

8.  Phenotypic and genotypic characterisation of Blastocystis hominis isolates implicates subtype 3 as a subtype with pathogenic potential.

Authors:  T C Tan; K G Suresh; H V Smith
Journal:  Parasitol Res       Date:  2008-09-16       Impact factor: 2.289

9.  Geographic diversity among genotypes of Entamoeba histolytica field isolates.

Authors:  Ali Haghighi; Seiki Kobayashi; Tsutomu Takeuchi; Nitaya Thammapalerd; Tomoyoshi Nozaki
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

10.  Identification of differentially expressed genes in virulent and nonvirulent Entamoeba species: potential implications for amebic pathogenesis.

Authors:  Ryan C MacFarlane; Upinder Singh
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.